Welsh, Carson, Anderson & Stowe was dismissed from an antitrust case brought by the Federal Trade Commission against U.S. Anesthesia Partners (USAP). The FTC alleged that USAP monopolized markets in Texas to raise prices. While Welsh Carson’s dismissal was a victory for private equity firms, the case against USAP continues. This decision will maintain scrutiny on companies, like USAP, that have been acquiring physician groups. The ruling highlights concerns within the industry that the Biden administration may hold private equity firms responsible for the actions of their portfolio companies. The case sheds light on the ongoing challenges surrounding antitrust issues in healthcare.
Source link
Welsh Carson private equity firm escapes from FTC antitrust case
